Rnt (RNT) is 785.8× the size of Lympid (LYP) by market capitalisation. Their daily returns move loosely in opposite directions (correlation -0.39 across 44 shared trading days). LYP has been the more volatile of the two, at 120% annualised against RNT's 21%.
LYPRNT
-0.39over 44 shared trading days
Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.
| Metric | LYP | RNT |
|---|---|---|
| Max drawdown (400d) | -95.0% | -1.3% |
| Risk-adjusted return (90d) | -0.45 | 1.12 |
| Best 30 days (past year) | +37.3% | — |
| Worst 30 days (past year) | -63.5% | — |
Relative strength over 90 days: RNT outperformed LYP by 51.2% — measured on the LYP/RNT ratio, so it holds regardless of market direction.